BeStock  
Markets › Compare › AVBP vs CGEM

AVBP vs CGEM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AVBP · ArriVent BioPharma$10.52 ▼ 6.57%
CGEM · Cullinan Therapeutics$8.89 ▼ 1.98%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4177113149185Nov 24, '25May 26, '26Nov 20, '26
  • AVBP -51.1%
  • CGEM -31.2%

Head to head

MetricAVBPCGEM
Price$10.52$8.89
Change today▼ 6.57%▼ 1.98%
Market cap$544.13M$577.15M
Return, 3 months-62.8%-59.3%
Return, year to date-47.7%-14.1%
Return, 1 year-48.3%-6.1%
P/E (TTM)––
P/B1.42.1
P/E percentile vs own 5y99th53rd
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-29.5%+2.4%
Gross margin––
Operating margin––
Net margin––
Return on equity-49.8%-55.5%
Analyst target vs. price+166.2%+282.5%
Analyst buy share100%100%
RSI (14)2926
30-day volatility125.3%102.2%
Max drawdown, 1 year-69.7%-61.3%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CGEM is the largest of the group by market value.
  • CGEM has returned the most over the past year.
  • CGEM has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top